PTHS: the cashflow

MyFinsight

For the quarter ending 2025-09-30, PTHS had $14,194,271 increase in cash & cash equivalents over the period.

Unit: Dollar

Cash Flow	2025-09-30	2025-06-30
Net loss	-16,238,450	-5,416,550
Accretion of interest for royalty obligations	1,316,000	-
Accrued compensation	-	23,636
Depreciation of property and equipment	389,000	-
Accounts payable and accrued expenses	-	3,102,476
Amortization of intangibles	679,000	-
Amortization of debt discount	109	258,891
Lease amortization expense	74,000	-
Stock-based compensation	2,762,683	899,317
Inventory write-off	792,000	-
Accounts receivable	7,940,000	-
Inventory	-1,385,000	-
Prepaid expenses	1,463,959	-52,959
Operating lease right-of-use assets	243,000	-
Accounts payable	4,031,000	-
Accrued expenses	2,689,000	-
Operating lease liabilities	-189,000	-
Deferred revenue	294,000	-
Deferred income tax	-465,000	-
Due from chromocell corporation	-	0
Other assets and liabilities	-97,000	-
Net cash used in operating activities	-15,258,729	-1,079,271
Acquisition of lnhc, inc	-2,761,000	-
Net cash provided by investing activities	2,761,000	-
Proceeds from loan payable, net of debt discount - related party	-	0
Proceeds from pipe, net	27,384,000	-
Common stock issued for cash	-	0
Proceeds from stock option exercises	85,000	-
Proceeds from loan payable, net of debt discount	68,000	625,000
Recission of common stock	-	0
Payment of loan payable, net of debt discount	-845,000	0
Net cash provided by financing activities	26,692,000	625,000
Net increase in cash and cash equivalents	14,194,271	-454,271
Cash and cash equivalents at beginning of period	513,000	-
Cash and cash equivalents at end of period	14,253,000	-

Unit: Dollar